Navigation Links
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Date:2/9/2011

ROCKVILLE, Md., Feb. 9, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"Congress passed the Orphan Drug Act because it recognized that adequate drugs for many rare diseases have not been developed," said Richard Garr, president and CEO of Neuralstem. "The designation of our spinal cord stem cells as an orphan drug underscores the importance of developing effective treatments for patients with ALS. In addition to providing a seven-year term of market exclusivity for our stem cells for ALS upon FDA approval, Orphan Drug Designation also positions Neuralstem to take advantage of certain financial and regulatory benefits, including government grants for conducting clinical trials, waiver of FDA user fees for the submission of a Biologics License Application for NSI-566RSC, and certain tax credits. It is an important step forward for the company."

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in a FDA-approved Phase I safety clinical trial for Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's disease.

In addition to ALS, the company is also targeting major central nervous system diseases, including
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
2. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
3. Neuralstems ALS Trial on Clinical Hold
4. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
5. Neuralstem Announces Issuance of Core Technology Patent in Europe
6. Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels
7. Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential
8. Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011
9. Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S.
10. The Villages Charter School Receives Donation From Praxis EMR
11. Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... GLEN BURNIE, Md. , April 1, 2015 ... in patient recruitment solutions for the clinical research ... to help with a dermatology study that was ... its expert recruitment strategies and customized site support ... was screening and enrolling, and also increased the ...
(Date:4/1/2015)... 2015  The U.S. Food and Drug Administration ... wireless maternal/fetal monitoring system to be marketed ... to self-administer non-stress tests (NST). Sense4Baby ... use accompanied by medical professionals. Sense4Baby also received ... 2013 for self-administration, including the home. ...
(Date:4/1/2015)... MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... Annual Needham Healthcare Conference on Wednesday, April 15, 2015 ... Hotel in New York . A live ... . A replay will be available approximately one hour after ...
Breaking Medicine Technology:CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4MEI Pharma to Present at Needham Healthcare Conference 2
... May 24, 2007 - Generex ... Dr. Douglas Powell, Director,of Immunobiology ... subsidiary,has presented Antigen's vaccine development ... London, UK. The international meeting,"Developing ...
... Inc., (NASDAQ:,GTXI) announced today that data from the ... Ostarine(TM) and from the ongoing Phase,III clinical trial ... of multiple side effects of androgen,deprivation therapy (ADT) ... of the American Society of Clinical Oncology being,held ...
Cached Medicine Technology:Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 2Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 3GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3
(Date:4/2/2015)... April 02, 2015 “ SmartenFit ” was ... takes a look at the latest and coolest ... Troohey, the host of AppWatch and technology expert, conducted the ... for people looking for a sustainable healthy lifestyle. , Health ... SmartenFit is a new application that covers health from a ...
(Date:4/2/2015)... April 02, 2015 As spring weather ... gets its start! Runners have been putting in the ... start racing. Zensah®, a premium compression apparel brand, is ... the athletes are benefiting from compression in ... a Miami-based company, committed to using the best fabrics ...
(Date:4/2/2015)... April 02, 2015 Memphis, TN: MedixSafe Vanguard ... safes, cabinets, and lockers to meet security demands ... facility down to an ambulance service keeping limited narcotics ... 2 provides triple security-plus technology® with a wireless connection ... to monitor narcotics access 24/7. , MedixSafe Vanguard 2 ...
(Date:4/2/2015)... New York Dynamic Neuromuscular Rehabilitation & Physical ... New York City, a groundbreaking, conservative method of treatment ... other types of neurological diseases that damage the ability ... is considered a cerebrovascular accident (CVA) that causes an ... in damage to the nerve cells. Damage to the ...
(Date:4/1/2015)... In April, the Science Museum of Virginia will ... by illuminating Richmond’s historic train station with blue lights. ... of businesses, schools and organizations who will ‘go blue’ ... up the night sky – and the future of ... the 8th annual awareness campaign spearheaded by Autism Speaks, ...
Breaking Medicine News(10 mins):Health News:An Application for Long Term Sustainable Lifestyle Change Was Featured on NewsWatch Television 2Health News:Zensah® Partners With Austin Track Club 2Health News:Zensah® Partners With Austin Track Club 3Health News:MedixSafe Introduces New High Tech Narcotics Security Solution - Vanguard 2 2Health News:Virtual Environment Treatment Available for the First Time in NYC for Patients with Stroke 2
... exposure to toxic chemicals and chronic diseases, especially in ... efforts to protect the public from hazardous chemicals, say ... Affairs . The Environmental Protection Agency (EPA), stymied by ... in academia to help evaluate the risks of industrial ...
... News) -- It costs $26 billion a year to ... as atrial fibrillation, according to a new study. ... $9.9 billion for other cardiovascular risk factors or disease ... said. "Atrial fibrillation places a huge economic burden ...
... 3, 2011) Since the 1930s scientists have proposed food ... feeding a reduced-calorie diet has indeed lengthened the life spans ... dozens of different mouse strains indicate that food restriction does ... loss , Researchers at the UT Health Science Center San ...
... News) -- Obesity may lower levels of sexual satisfaction, ... University researchers studied 91 obese men and 134 obese ... in a weight loss study. The questionnaire covered nine ... and sexual problems. "We found that there was ...
... , TUESDAY, May 3 (HealthDay News) -- Magnetic resonance ... most cases where a biopsy fails to do so, a ... were able to correctly identify the type of cancer in ... biopsy results. More than 43,000 women were newly ...
... A five-year $4.5 million USDA grant to University ... Prevention Program (I-TOPP), an innovative research-based program that will ... (MPH) degree focused on child obesity prevention. "This ... and approaches as researchers come together from their individual ...
Cached Medicine News:Health News:US must strengthen efforts to restrict chemicals that threaten health, say researchers 2Health News:US must strengthen efforts to restrict chemicals that threaten health, say researchers 3Health News:Care for Irregular Heartbeat Costs U.S. Billions: Study 2Health News:Mouse study turns fat-loss/longevity link on its head 2Health News:Obese People Have Less Satisfying Sex Lives: Study 2Health News:MRIs Can Tell Endometrial, Cervical Cancer Apart: Study 2Health News:$4.5 million grant creates transdisciplinary program to train scholars in child obesity prevention 2Health News:$4.5 million grant creates transdisciplinary program to train scholars in child obesity prevention 3Health News:$4.5 million grant creates transdisciplinary program to train scholars in child obesity prevention 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: